These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

485 related items for PubMed ID: 9836841

  • 1. Wound management in an era of increasing bacterial antibiotic resistance: a role for topical silver treatment.
    Wright JB, Lam K, Burrell RE.
    Am J Infect Control; 1998 Dec; 26(6):572-7. PubMed ID: 9836841
    [Abstract] [Full Text] [Related]

  • 2. Bacterial resistance to silver in wound care.
    Percival SL, Bowler PG, Russell D.
    J Hosp Infect; 2005 May; 60(1):1-7. PubMed ID: 15823649
    [Abstract] [Full Text] [Related]

  • 3. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial-thickness burn wounds.
    Muangman P, Chuntrasakul C, Silthram S, Suvanchote S, Benjathanung R, Kittidacha S, Rueksomtawin S.
    J Med Assoc Thai; 2006 Jul; 89(7):953-8. PubMed ID: 16881426
    [Abstract] [Full Text] [Related]

  • 4. [Effect of silver nanoparticle dressing on second degree burn wound].
    Chen J, Han CM, Lin XW, Tang ZJ, Su SJ.
    Zhonghua Wai Ke Za Zhi; 2006 Jan 01; 44(1):50-2. PubMed ID: 16620649
    [Abstract] [Full Text] [Related]

  • 5. Comparison of silver sulfadiazine and gentamicin for topical prophylaxis against burn wound sepsis.
    Snelling CF, Ronald AR, Waters WR, Yaworski DS, Drulak K, Sunderland M.
    Can Med Assoc J; 1978 Sep 09; 119(5):466-70. PubMed ID: 99223
    [Abstract] [Full Text] [Related]

  • 6. [Multi-center clinical study of the effect of silver nitrate ointment on the partial-thickness burn wounds].
    Liao ZJ, Huan JN, Lv GZ, Shou YM, Wang ZY.
    Zhonghua Shao Shang Za Zhi; 2006 Oct 09; 22(5):359-61. PubMed ID: 17285717
    [Abstract] [Full Text] [Related]

  • 7. [The use of a topical antibacterial agent (silver sulfadiazine) on soft-tissue wounds].
    Bocchiotti G, Robotti E.
    Minerva Chir; 1990 May 15; 45(9):677-81. PubMed ID: 2202932
    [Abstract] [Full Text] [Related]

  • 8. Benefit of hydrocolloid SSD dressing in the outpatient management of partial thickness burns.
    Muangman P, Muangman S, Opasanon S, Keorochana K, Chuntrasakul C.
    J Med Assoc Thai; 2009 Oct 15; 92(10):1300-5. PubMed ID: 19845237
    [Abstract] [Full Text] [Related]

  • 9. Construction, application and biosafety of silver nanocrystalline chitosan wound dressing.
    Lu S, Gao W, Gu HY.
    Burns; 2008 Aug 15; 34(5):623-8. PubMed ID: 18226459
    [Abstract] [Full Text] [Related]

  • 10. Silver dressings in clinical practice.
    Driver VR.
    Ostomy Wound Manage; 2004 Sep 15; 50(9A Suppl):11S-15S. PubMed ID: 15499163
    [Abstract] [Full Text] [Related]

  • 11. An in vitro model of chronic wound biofilms to test wound dressings and assess antimicrobial susceptibilities.
    Hill KE, Malic S, McKee R, Rennison T, Harding KG, Williams DW, Thomas DW.
    J Antimicrob Chemother; 2010 Jun 15; 65(6):1195-206. PubMed ID: 20378671
    [Abstract] [Full Text] [Related]

  • 12. Topical silver for preventing wound infection.
    Storm-Versloot MN, Vos CG, Ubbink DT, Vermeulen H.
    Cochrane Database Syst Rev; 2010 Mar 17; (3):CD006478. PubMed ID: 20238345
    [Abstract] [Full Text] [Related]

  • 13. A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis.
    Huang Y, Li X, Liao Z, Zhang G, Liu Q, Tang J, Peng Y, Liu X, Luo Q.
    Burns; 2007 Mar 17; 33(2):161-6. PubMed ID: 17175106
    [Abstract] [Full Text] [Related]

  • 14. Use of Acticoat dressings in burns: what is the evidence?
    Khundkar R, Malic C, Burge T.
    Burns; 2010 Sep 17; 36(6):751-8. PubMed ID: 20346592
    [Abstract] [Full Text] [Related]

  • 15. Arglaes controlled release dressing in the control of bacteria.
    Williams C.
    Br J Nurs; 2010 Sep 17; 6(2):114-5. PubMed ID: 9116437
    [Abstract] [Full Text] [Related]

  • 16. Control of experimental burn wound infections: comparative delivery of the antimicrobial agent (silver sulfadiazine) either from a cream base or from a solid synthetic dressing.
    Robb EC, Nathan P.
    J Trauma; 1981 Oct 17; 21(10):889-93. PubMed ID: 7277534
    [Abstract] [Full Text] [Related]

  • 17. Nanocrystalline silver dressings as an efficient anti-MRSA barrier: a new solution to an increasing problem.
    Strohal R, Schelling M, Takacs M, Jurecka W, Gruber U, Offner F.
    J Hosp Infect; 2005 Jul 17; 60(3):226-30. PubMed ID: 15896880
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Antimicrobial effect. Comparison of wound dressings containing silver].
    Krankenpfl J; 2003 Jul 17; 41(10-12):216-7. PubMed ID: 14746197
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.